<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="0d91895e-c869-4b33-9b83-d55c1ad6317e"><labelDrug name="Avalide"><Normalization><mmtx cui="C0875966" preferredWord="Avalide" semType="phsu, orch"/></Normalization></labelDrug><generic name="irbesartan and hydrochlorothiazide"/><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1" text="Drug Label for drug brand Avalide, containing irbesartan and hydrochlorothiazide." type="negative"><entity charOffset="26:33" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.0" text="avalide" type="Biomedical_Entity"><Normalization><mmtx cui="C0875966" phraseText="Drug Label for drug brand Avalide," preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="46:56" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.1" text="irbesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0288171" phraseText="irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="61:80" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.3" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Avalide," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.1.e.2"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.15" text="&lt;item&gt;Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="137:148" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.15.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="21:40" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.15.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.15.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.15.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16" lineNumber="35" text="&lt;item&gt;Do not coadminister aliskiren with AVALIDE in patients with diabetes see Drug Interactions (7)." type="regular"><entity charOffset="6:25" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="66:74" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="41:48" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.3" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="aliskiren with AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with AVALIDE" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.1"><relations><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.2" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.16.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20" lineNumber="47" text="&lt;item&gt;Do not coadminister aliskiren with AVALIDE in patients with diabetes (4)" type="regular"><entity charOffset="6:25" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="26:35" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with AVALIDE" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="41:48" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.3" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="aliskiren with AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="66:74" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.4" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.20.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.38" text="Excessive reduction of blood pressure was rarely seen in patients with uncomplicated hypertension treated with irbesartan alone ( 0.1%) or with irbesartan-hydrochlorothiazide (approximately 1%). " type="negative"><entity charOffset="111:121" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.38.e.0" text="irbesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0288171" phraseText="treated with irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="144:174" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.38.e.1" text="irbesartan-hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717823" phraseText="or with irbesartan-hydrochlorothiazide" preferredWord="Hydrochlorothiazide / irbesartan" semType="phsu, orch"/><RxNorm RxCui="214617"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.38.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.38.e.1"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39" text="Initiation of antihypertensive therapy may cause symptomatic hypotension in patients with intravascular volume- or sodium-depletion, e.g., in patients treated vigorously with diuretics or in patients on dialysis. " type="negative"><entity charOffset="14:30" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="Initiation of antihypertensive therapy" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="115:121" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="sodium-depletion," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="175:184" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="vigorously with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.39.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49" lineNumber="90" text="Lithium generally should not be given with thiazides. " type="regular"><entity charOffset="25:37" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="43:52" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.2" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides." preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.49.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53" lineNumber="95" text="In double-blind clinical trials of various doses of irbesartan and hydrochlorothiazide, the incidence of hypertensive patients who developed hypokalemia (serum potassium 3.5 mEq/L) was 7.5% versus 6.0% for placebo, the incidence of hyperkalemia (serum potassium 5.7 mEq/L) was 1.0% versus 1.7% for placebo. " type="regular"><entity charOffset="141:152" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.1" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="3:31" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.2" text="double-blind clinical trials" type="SPAN"><Normalization><mmtx cui="C0456909" phraseText="In double-blind clinical trials" preferredWord="Blind Vision" semType="dsyn"/></Normalization></entity><entity charOffset="52:62" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.3" text="irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="of irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="67:86" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.4" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="105:126" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.5" text="hypertensive patients" type="SPAN"/><entity charOffset="232:244" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.7" text="hyperkalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.1"><relations><relation type="hasEvidence"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.7"><relations><relation type="hasEvidence"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.5" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.4" evidence="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.53.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55" text="On average, the combination of irbesartan and hydrochlorothiazide had no effect on serum potassium. " type="negative"><entity charOffset="89:98" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="no effect on serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="31:41" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.2" text="irbesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0288171" phraseText="the combination of irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.55.e.1"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.56" text="Higher doses of irbesartan ameliorated the hypokalemic response to hydrochlorothiazide." type="negative"><entity charOffset="16:26" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.56.e.0" text="irbesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0288171" phraseText="Higher doses of irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="67:86" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.56.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="the hypokalemic response to hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.56.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.56.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57" lineNumber="96" text="Based on experience with the use of other drugs that affect the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium. " type="regular"><entity charOffset="214:242" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.1" text="increases in serum potassium" type="Specific_Interaction"/><entity charOffset="109:136" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.2" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="164:201" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.3" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="42:88" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.4" text="drugs that affect the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="of other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="138:159" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.5" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.5" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.3"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.5"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.5" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.57.e.3"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.64" text="Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides." type="negative"><entity charOffset="30:37" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.64.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose tolerance" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.64.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.64.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.64.e.0"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.66" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="31:38" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.66.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.66.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.66.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.66.e.0"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.67" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="63:70" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.67.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="slight elevation of serum calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.67.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.67.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.67.e.0"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.73" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals see Drug Interactions (7). " type="negative"><entity charOffset="53:64" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.73.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.73.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.73.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.73.e.0"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74" text="In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with ACE inhibitors has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="174:188" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.2" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.74.e.2"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82" text="Sulfonamide or sulfonamide derivative drugs, such as hydrochlorothiazide, can cause an idiosyncratic reaction, resulting in transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="53:72" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="such as hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.1" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="Sulfonamide" preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:26" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.2" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="sulfonamide derivative drugs," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.82.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" lineNumber="122" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. " type="irregular"><entity charOffset="96:127" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.1" text="loss of antihypertensive effect" type="Specific_Interaction"/><entity charOffset="17:43" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="6:12" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.5" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="lead to increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="lead to increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92" lineNumber="122" text="Monitor renal function periodically." type="irregular"><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92.e.1" text="Monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.3"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93" lineNumber="124" text="&lt;item&gt;Dual blockade of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia." type="irregular"><entity charOffset="89:100" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="6:51" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.2" text="Dual blockade of the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C3540676" phraseText="&gt;Dual blockade of the renin-angiotensin system" preferredWord="Blockade" semType="phsu"/><mmtx cui="C0035100" phraseText="&gt;Dual blockade of the renin-angiotensin system" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="&gt;Dual blockade of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="222215"/></Normalization></entity><entity charOffset="106:118" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.4" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="71:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.6" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="Increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="Increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92" text="Monitor renal function periodically."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92" text="Monitor renal function periodically."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.ddi.3"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90" text="&lt;main&gt;Irbesartan (7):"><entity charOffset="6:16" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.90.e.0" text="Irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="&gt;Irbesartan" preferredWord="irbesartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.91" text="&lt;item&gt;NSAIDs and selective COX-2 inhibitors: May lead to increased risk of renal impairment and loss of antihypertensive effect. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.92" text="Monitor renal function periodically."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.93.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95" lineNumber="128" text="&lt;item&gt;Antidiabetic drugs: Dosage adjustment of antidiabetic may be required" type="irregular"><anaphoraRelation><anaphoraEntity charOffset="47:59" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.2" text="antidiabetic" type="Expression"/><antecedentEntity charOffset="6-24" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.4" text="Antidiabetic drugs" type="Drug_Class"/></anaphoraRelation><entity charOffset="26:43" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.1" text="Dosage adjustment" type="Caution_Interaction"/><entity charOffset="6:24" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.4" text="Antidiabetic drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="&gt;Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.94" text="&lt;item&gt;Hydrochlorothiazide (7):"><entity charOffset="6:25" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.94.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="&gt;Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96" lineNumber="130" text="&lt;item&gt;Cholestyramine and colestipol: Reduced absorption of thiazides" type="regular"><entity charOffset="37:55" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.1" text="Reduced absorption" type="Decrease_Interaction"/><entity charOffset="59:68" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.2" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Reduced absorption of thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="6:20" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.3" text="Cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="&gt;Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="25:35" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.4" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.1" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97" lineNumber="132" text="&lt;item&gt;Lithium: Reduced renal clearance and high risk of lithium toxicity when used with diuretics. " type="regular"><entity charOffset="15:38" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.1" text="Reduced renal clearance" type="Increase_Interaction"/><entity charOffset="56:63" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="high risk of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="88:97" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="used with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="64:72" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.5" text="toxicity" type="Increase_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.5"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98" lineNumber="132" text="Should not be given with diuretics." type="irregular"><entity charOffset="7:19" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="25:34" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98.e.2" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97" text="&lt;item&gt;Lithium: Reduced renal clearance and high risk of lithium toxicity when used with diuretics. "><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99" lineNumber="134" text="&lt;item&gt;NSAIDs: Can reduce diuretic, natriuretic, and antihypertensive effects of diuretics and increase risk for renal impairment." type="regular"><entity charOffset="18:33|69:76" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.1" text="reduce diuretic effects" type="Specific_Interaction"/><entity charOffset="6:12" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="antihypertensive effects of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="18:24|52:76" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.5" text="reduce antihypertensive effects" type="Specific_Interaction"/><entity charOffset="18:24|35:46|69:76" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.7" text="reduce natriuretic effects" type="Specific_Interaction"/><entity charOffset="112:128" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.9" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="increase risk for renal impairment." preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="increase risk for renal impairment." preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.ddi.3"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.ddi.4"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100" lineNumber="136" text="&lt;item&gt;Carbamazepine: Increased risk of hyponatremia." type="irregular"><entity charOffset="39:51" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.e.1" text="hyponatremia" type="Specific_Interaction"><Normalization><mmtx cui="C0857122" phraseText="Increased risk of hyponatremia." preferredWord="hyponatremic" semType="dsyn"/></Normalization></entity><entity charOffset="6:19" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.e.2" text="Carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="&gt;Carbamazepine" preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.94" text="&lt;item&gt;Hydrochlorothiazide (7):"><entity charOffset="6:25" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.94.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="&gt;Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.95" text="&lt;item&gt;Antidiabetic drugs: Dosage adjustment of antidiabetic may be required"/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.96" text="&lt;item&gt;Cholestyramine and colestipol: Reduced absorption of thiazides"/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.97" text="&lt;item&gt;Lithium: Reduced renal clearance and high risk of lithium toxicity when used with diuretics. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.98" text="Should not be given with diuretics."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.99" text="&lt;item&gt;NSAIDs: Can reduce diuretic, natriuretic, and antihypertensive effects of diuretics and increase risk for renal impairment."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.100.e.2"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102" text="No significant drug-drug interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine. " type="negative"><entity charOffset="112:120" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="126:136" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.1" text="nifedipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028066" phraseText="nifedipine." preferredWord="Nifedipine" semType="phsu, orch"/><RxNorm RxCui="7417"/></Normalization></entity><entity charOffset="82:101" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="studies with hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="103:110" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.1"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.102.e.3"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104" text="Non-Steroidal Anti-Inflammatory Agents Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="88:104" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.0" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="0:38" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.1" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.2" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.104.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105" lineNumber="142" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including irbesartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="191:226" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="238:248" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.2" text="irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="irbesartan," preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="264:295" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.4" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="92:118" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.5" text="compromised renal function" type="SPAN"/><entity charOffset="29:44" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.6" text="volume-depleted" type="SPAN"/><entity charOffset="140:146" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.7" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="coadministration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="20:27" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.8" text="elderly" type="SPAN"/><entity charOffset="158:184" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.10" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="316:335" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.2" drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.1"/><classClassMembership drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.10"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.4"><relations><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.12"><relations><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.6, Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.5, Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.8" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.7" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.1" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.105.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107" lineNumber="142" text="Monitor renal function periodically in patients receiving irbesartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:68" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.2" text="irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="irbesartan" preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.107.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108" lineNumber="143" text="The antihypertensive effect of angiotensin II receptor antagonists, including irbesartan, may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.2" text="irbesartan" type="Drug"><Normalization><mmtx cui="C0288171" phraseText="irbesartan," preferredWord="irbesartan" semType="phsu, orch"/><RxNorm RxCui="83818"/></Normalization></entity><entity charOffset="4:27|97:107" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.4" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="111:117" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.5" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="128:154" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.7" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><drugClassMembership drug="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.2" drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.1"/><classClassMembership drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.7"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.5" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.108.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.109" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.109.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.109.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.109.e.0" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.109.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110" lineNumber="145" text="Dual blockade of the RAS with angiotensin-receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="128:139" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="61:75" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="30:59" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4" text="angiotensin-receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin-receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin-receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="9164"/></Normalization></entity><entity charOffset="141:153" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.6" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.8" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.10" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4"/></relation><relation type="hasObject"><labelDrug text="Avalide"/><normalization><mmtx><preferredWord>Avalide</preferredWord><phraseText>aliskiren with AVALIDE</phraseText><cuiCode>C0875966</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4"/></relation><relation type="hasObject"><labelDrug text="Avalide"/><normalization><mmtx><preferredWord>Avalide</preferredWord><phraseText>aliskiren with AVALIDE</phraseText><cuiCode>C0875966</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.ddi.3"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4"/></relation><relation type="hasObject"><labelDrug text="Avalide"/><normalization><mmtx><preferredWord>Avalide</preferredWord><phraseText>aliskiren with AVALIDE</phraseText><cuiCode>C0875966</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.ddi.4"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4"/></relation><relation type="hasObject"><labelDrug text="Avalide"/><normalization><mmtx><preferredWord>Avalide</preferredWord><phraseText>aliskiren with AVALIDE</phraseText><cuiCode>C0875966</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.110.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111" lineNumber="145" text="Closely monitor blood pressure, renal function, and electrolytes in patients on AVALIDE and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.1" text="monitor" type="Caution_Interaction"/><entity charOffset="80:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.2" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="on AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="98:124" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.111.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112" lineNumber="146" text="Do not coadminister aliskiren with AVALIDE in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="35:42" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.2" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="aliskiren with AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.3" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with AVALIDE" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.3" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.112.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113" lineNumber="146" text="Avoid use of aliskiren with AVALIDE in patients with renal impairment (GFR 60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:35" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.3" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="with AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="53:69" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.4" ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.113.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" lineNumber="148" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="53:76" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.1" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.2" text="Narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="Narcotics" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.3" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.4" text="Barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="Barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.4" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.2"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116" lineNumber="149" text="Antidiabetic Drugs (oral agents and insulin): dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="71:88" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.2" text="insulin" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="71:88" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.4" text="Antidiabetic Drugs oral agents" type="Drug_Class"/></anaphoraRelation><entity charOffset="36:43" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.2" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="0:18|20:31" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.4" text="Antidiabetic Drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic Drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="46:63" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.6" text="dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur."/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118" text="Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="negative"><entity charOffset="52:71" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="19:29" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.1" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="Colestipol Resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.2" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.0"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" lineNumber="151" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.1" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.2" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="68:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="92:98|103:113" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.4" text="reduce absorption" type="Decrease_Interaction"/><entity charOffset="23:37" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.5" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.6" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.5" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.1" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.4" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.6" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.1" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.4" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.5" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.6"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120" lineNumber="151" text="AVALIDE should be taken at least one hour before or four hours after these medications." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" Text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><anaphoraEntity charOffset="69:86" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.2" text="these medications" type="Expression"/><antecedentEntity charOffset="23:37" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.5" text="cholestyramine" type="Drug"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" Text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><anaphoraEntity charOffset="69:86" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.2" text="these medications" type="Expression"/><antecedentEntity charOffset="41:51" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119.e.6" text="colestipol" type="Drug"/></anaphoraRelation><entity charOffset="18:23|42:51|63:68" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.1" text="taken before or after" type="Caution_Interaction"/><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.3" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121" lineNumber="152" text="Corticosteroids, ACTH: intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="23:56" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.1" text="intensified electrolyte depletion" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.2" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="17:21" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.3" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="71:82" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.5" text="hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116" text="Antidiabetic Drugs (oral agents and insulin): dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.117" text="Other Antihypertensive Drugs: additive effect or potentiation."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118" text="Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120" text="AVALIDE should be taken at least one hour before or four hours after these medications."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116" text="Antidiabetic Drugs (oral agents and insulin): dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.117" text="Other Antihypertensive Drugs: additive effect or potentiation."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118" text="Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120" text="AVALIDE should be taken at least one hour before or four hours after these medications."/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122" lineNumber="153" text="Pressor Amines ( e.g., Norepinephrine): possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="0:14" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.1" text="Pressor Amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor Amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="23:37" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.2" text="Norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="Norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="49:67" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.4" text="decreased response" type="Decrease_Interaction"/><entity charOffset="71:85" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.2" drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.1"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.4"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122.e.5"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116" text="Antidiabetic Drugs (oral agents and insulin): dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.117" text="Other Antihypertensive Drugs: additive effect or potentiation."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118" text="Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120" text="AVALIDE should be taken at least one hour before or four hours after these medications."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121" text="Corticosteroids, ACTH: intensified electrolyte depletion, particularly hypokalemia."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123" lineNumber="154" text="Skeletal Muscle Relaxants, Nondepolarizing ( e.g., Tubocurarine): possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="107:122" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.4" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-42" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.1" text="Skeletal Muscle Relaxants, Nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:42" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.1" text="Skeletal Muscle Relaxants, Nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal Muscle Relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.2" text="Tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="Tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="75:99" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.6" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.2" drugClass="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.1"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.114.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.115" text="Alcohol, Barbiturates, or Narcotics: potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.116" text="Antidiabetic Drugs (oral agents and insulin): dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.117" text="Other Antihypertensive Drugs: additive effect or potentiation."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.118" text="Cholestyramine and Colestipol Resins: absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.119" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.120" text="AVALIDE should be taken at least one hour before or four hours after these medications."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.121" text="Corticosteroids, ACTH: intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.122" text="Pressor Amines ( e.g., Norepinephrine): possible decreased response to pressor amines but not sufficient to preclude their use."/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.123.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124" lineNumber="155" text="Lithium: should not generally be given with diuretics. " type="regular"><entity charOffset="16:38" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.1" text="not generally be given" type="Caution_Interaction"/><entity charOffset="44:53" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.2" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.124.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125" lineNumber="155" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="16:42" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="0:15" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.2" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="46:53" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.6" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.125.e.5" type="Increase_Interaction"/></sentence><sentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.126" text="Refer to the package insert for lithium preparations before use of such preparations with AVALIDE. " type="negative"><entity charOffset="90:97" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.126.e.0" text="avalide" type="Biomedical_Entity"><Normalization><mmtx cui="C0875966" phraseText="with AVALIDE." preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.126.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.126.e.1" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.126.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128" lineNumber="156" text="Non-steroidal Anti-inflammatory Drugs: in some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing, and thiazide diuretics. " type="regular"><entity charOffset="123:142|178:185" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.1" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="81:118" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="189:193|227:236" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.3" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="218:236" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.4" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="195:212|227:236" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.5" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="123:133|144:155|178:185" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.7" text="reduce the natriuretic effects" type="Specific_Interaction"/><entity charOffset="123:133|161:185" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.9" text="reduce the antihypertensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.ddi.2"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.ddi.3"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.4" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.5" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.128.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129" lineNumber="156" text="Therefore, when AVALIDE (irbesartan-hydrochlorothiazide) Tablets and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="154:162" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.1" text="observed" type="Caution_Interaction"/><entity charOffset="16:23" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.2" text="AVALIDE" type="Drug"><Normalization><mmtx cui="C0875966" phraseText="AVALIDE" preferredWord="Avalide" semType="phsu, orch"/><RxNorm RxCui="261454"/></Normalization></entity><entity charOffset="69:107" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.3" text="non-steroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.2" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.3" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.129.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130" lineNumber="157" text="Carbamazepine: concomitant use of carbamazepine and hydrochlorothiazide has been associated with the risk of symptomatic hyponatremia. " type="regular"><entity charOffset="121:133" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.1" text="hyponatremia" type="Specific_Interaction"><Normalization><mmtx cui="C0857122" phraseText="associated with the risk of symptomatic hyponatremia." preferredWord="hyponatremic" semType="dsyn"/></Normalization></entity><entity charOffset="52:71" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="34:47" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.3" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="concomitant use of carbamazepine" preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.3" e2="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.2" trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.131" lineNumber="157" text="Electrolytes should be monitored during concomitant use." type="irregular"><entity charOffset="23:32" id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.131.e.1" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.131.ddi.1"><interaction trigger="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.131.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130" text="Carbamazepine: concomitant use of carbamazepine and hydrochlorothiazide has been associated with the risk of symptomatic hyponatremia. "><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130" text="Carbamazepine: concomitant use of carbamazepine and hydrochlorothiazide has been associated with the risk of symptomatic hyponatremia. "><entity id="Dailymed.0d91895e-c869-4b33-9b83-d55c1ad6317e.s.130.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><positiveExamples number="43"/><negativeExamples number="51"/></document>